# PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells

> **NCT01700920** · PHASE2 · COMPLETED · sponsor: **Red de Terapia Celular** · enrollment: 3 (actual)

## Conditions studied

- Osteonecrosis of the Femoral Head

## Interventions

- **PROCEDURE:** bone marrow aspirate

## Key facts

- **NCT ID:** NCT01700920
- **Lead sponsor:** Red de Terapia Celular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2017-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01700920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01700920, "PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01700920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*